LisaOstroskySproatMDMSW
Oncology • Scottsdale, AZClinical Director, Acute and Chronic Leukemia Program
Dr. Sproat is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
13400 E Shea Blvd
Scottsdale, AZ 85259Phone+1 480-301-8000
Education & Training
Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 2006 - 2009
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2000 - 2003
University of Vermont College of MedicineClass of 2000
Certifications & Licensure
AZ State Medical License 2009 - 2027
NM State Medical License 2015 - 2025
OH State Medical License 2005 - 2010
ME State Medical License Active through 2007
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- Factors associated with survival following allogeneic transplantation for myeloid neoplasms harboring TP53 mutations.Anmol Baranwal, Kimberly Langer, Vedavyas Gannamani, Danielle Rud, Alia Cibich
Blood Advances. 2025-03-14 - 3 citationsMayo Genetic Risk Models for Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax + Hypomethylating Agent.Naseema Gangat, Azeem Elbeih, Nour Ghosoun, Kristen McCullough, Fnu Aperna
American Journal of Hematology. 2025-02-01 - Surrogates of Endothelial Injury Predict Survival After Post-transplant Cyclophosphamide.Anmol Baranwal, Kimberly J Langer, Mohamed A Kharfan-Dabaja, Ernesto Ayala, James Foran
Transplantation and Cellular Therapy. 2025-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
